Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H15NO3 |
| Molecular Weight | 209.2417 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(O)(COC(N)=O)C1=CC=CC=C1
InChI
InChIKey=WAFIYOULDIWAKR-UHFFFAOYSA-N
InChI=1S/C11H15NO3/c1-2-11(14,8-15-10(12)13)9-6-4-3-5-7-9/h3-7,14H,2,8H2,1H3,(H2,12,13)
| Molecular Formula | C11H15NO3 |
| Molecular Weight | 209.2417 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://doi.org/10.1016/S0025-7125(16)33476-9 |
Sources: https://doi.org/10.1016/S0025-7125(16)33476-9 |
HYDROXYPHENAMATE (LISTICA®) is a carbamate tranquilizer indicated for anxiety. It resembles meprobamate in its effect.
CNS Activity
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://doi.org/10.1016/S0025-7125(16)33476-9
600 to 800 mg orally.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:52:09 GMT 2025
by
admin
on
Mon Mar 31 17:52:09 GMT 2025
|
| Record UNII |
MD0414799X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C554304
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
5752
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
100000083284
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
1397
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
SUB09565MIG
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
DTXSID40861571
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
1349
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
50-19-1
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
m768
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL2107215
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
Hydroxyphenamate
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
200-017-5
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
C76011
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
108034
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY | |||
|
MD0414799X
Created by
admin on Mon Mar 31 17:52:09 GMT 2025 , Edited by admin on Mon Mar 31 17:52:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |